Peptic esophagitis

Related records

Broader conditions (12)

• Digestive system disorder
• Disease
• Disease by body system or component
• Disease by developmental or physiological process
• Esophageal disorder
• Esophageal ulcer
• Esophagitis
• Human disease
• Inflammatory disease
• Peptic ulcer disease
• Ulcer disease
• Upper digestive tract disorder

Trials (121)

• 24 Hour Esophageal and Electrogastrography to Investigate the Mechanism of Reflux Esophagitis
• A Clinical Trial of Anaprazole for Treating Reflux Esophagitis.
• A Multi-center, Randomized, Double-blind Phase III Clinical Trial to Assess and Compare to the Efficacy and Safety of Lafutidine, Famotidine and Omeprazole-referenced in Korean Erosive Esophagitis Patients
• A Multicenter, Randomized, Double Blind, Double Dummy, Parallel-Group Efficacy Study Comparing 8 Weeks of Treatment With Esomeprazole Magnesium (40mg qd) to Lansoprazole (30mg qd) for the Healing of Erosive Esophagitis in Patients With Moderate or Severe Erosive Esophagitis
• A Novel Endoloop Pre-test to Treat Gastroesophageal Reflux
• A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related Diseases
• A Phase III Clinical Trial for Efficacy and Safety Evaluation of JP-1366 Tablets on Reflux Esophagitis
• A Prospective Cohort Study on Endoscopic Features of Upper Gastrointestinal Tract at High Altitude (Zaduo County)
• A Randomized, Double-Blind, Multicenter Study to Evaluate the Acid-inhibitory and Dose-response Efficacy of TAK-438 (20 mg, 40 mg) in Patients With Proton Pump Inhibitor (PPI) - Resistant Erosive Esophagitis
• A Study in Patients With Erosive Esophagitis to Investigate Safety, Tolerability, and Healing Rates After 4 Weeks Treatment of X842 or Lansoprazole and Symptom Pattern During Subsequent 4 Weeks Treatment With Lansoprazole
• A Study of Anaprazole Sodium Enteric-coated Tablets in the Treatment of Reflux Esophagitis
• A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer
• A Study of the Effects of Multiple Doses of Dexlansoprazole, Lansoprazole, Omeprazole or Esomeprazole on the Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Participants.
• A Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring
• A Study on Vonoprazan in the Real-world Clinical Practice in China
• A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old
• A Study to Compare the Pharmacokinetic Characteristics of CJ-12420
• A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Erosive Esophagitis
• A Study to Evaluate the Long-Term Safety of BLI5100 in Patients With Gastroesophageal Reflux Disease
• A Study to Evaluate the Safety, Tolerability and Pharmacokinetics/Pharmacodynamics of Oral Doses of H008

Approved drugs (2)

• Esomeprazole magnesium
• Vonoprazan fumarate

Drugs in development (20)

• Abeprazan Phase 3
• Anaprazole Phase 3
• Anaprazole sodium Phase 2
• Dexlansoprazole Phase 3
• Esomeprazole Phase 3
• Esomeprazole potassium Phase 3
• Famotidine Phase 3
• Ilaprazole Phase 2
• Lafutidine Phase 3
• Lanreotide Phase 2
• Lansoprazole Phase 3
• Linaprazan Phase 2
• Netazepide Phase 1
• Omeprazole Phase 3
• Omeprazole magnesium Phase 3
• Omeprazole sodium Phase 3
• Rabeprazole Phase 3
• Rabeprazole sodium Phase 2
• Ranitidine Phase 1
• Tenatoprazole Phase 2

Other linked drugs (2)

• Chlorpromazine
• Vonoprazan